Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma

Thoracic and Cardiovascular Surgeon

Volumn 57, Issue 7, 2009, Pages 403-408

  Pfannschmidt, J ^a   Bade, S ^a   Hoheisel, J ^b   Muley, T ^c   Dienemann, H ^a   Herpel, E ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Colorectal cancer; Metastasectomy; Thoracic surgery

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; MELANOMA ANTIGEN; TRANSCRIPTION FACTOR FOSB; VASCULOTROPIN D;

ADULT; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; HUMAN; LIVER METASTASIS; LUNG METASTASIS; LUNG RESECTION; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; THORACOTOMY; TUMOR LOCALIZATION;

AGED; ANTIGENS, NEOPLASM; CARCINOEMBRYONIC ANTIGEN; CARCINOMA; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; PNEUMONECTOMY; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROTO-ONCOGENE PROTEINS C-FOS; RISK ASSESSMENT; THORACOTOMY; TIME FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR D;

EID: 70350516589     PISSN: 01716425     EISSN: 14391902     Source Type: Journal    
DOI: 10.1055/s-0029-1185820     Document Type: Article

References (24)

1. Pfannschmidt J, Dienemann H, Hoffmann H. Surgical resection of pulmonary metastases from colorectal cancer: a systematic review of published series. Ann Thorac Surg 2007; 84 (1): 324-338 (Pubitemid 46921128)
2. Treasure T, Utley M, Hunt I. When professional opinion is not enough. BMJ 2007; 334 (7598): 831-832
3. Pfannschmidt J. Chirurgie der Lungenmetastasen - Klinische und molekularbiologische Prognoseparameter [Habilitation]. Heidelberg: Ruprecht-Karls-Universität Heidelberg; 2006
4. Abel U, Berger J, Wiebelt H. CRITLEVEL: an exploratory procedure for the evaluation of quantitative prognostic factors. Methods Inf Med 1984; 23(3): 154-156 (Pubitemid 14002516)
5. Kaplan E, Meier P. Non-parametric estimation from incomplete observations. J. Am Stat Assoc 1958; 53: 457-481
6. Peto R, Peto J. Asymptomatically efficient rank invariant test procedures. JR Stat Soc A 1972; 135; 185-198
7. Cox D. Regression models and life-table (with discussion). JR Stat Soc B 1972; 34: 187-220
8. Melloni G, Doglioni C, Bandiera A et al. Prognostic factors and analysis of microsatellite instability in resected pulmonary metastases from colorectal carcinoma. Ann Thorac Surg 2006; 81 (6): 2008-2013 (Pubitemid 43775542)
9. Shiono S, Ishii G, Nagai K et al. Histopathologic prognostic factors in resected colorectal lung metastases. Ann Thorac Surg 2005; 79 (1): 278-282; discussion 283 (Pubitemid 40037485)
10. Shiono S, Ishii G, Nagai K et al. Immunohistochemical prognostic factors in resected colorectal lung metastases using tissue rnicroarray analysis. Eur J Surg Oncol 2006; 32 (3): 308-309
11. Kayser K, Zink S, Andre S et al. Primary colorectal carcinomas and their intrapulmonary metastases: clinical, glyco-, immuno- and lectin histochemical, nuclear and syntactic structure analysis with emphasis on correlation with period of occurrence of metastases and survival. Apmis 2002; 110 (6): 435-446 (Pubitemid 34856485)
12. Tamura M, Oda M, Tsunezuka Y, Matsumoto I, Kawakami K, Watanabe G. Vascular endothelial growth factor expression in metastatic pulmonary tumor from colorectal carcinoma: utility as a prognostic factor. J Thorac Cardiovasc Surg 2004; 128(4): 517-522 (Pubitemid 39278384)
13. Cao Y. Opinion: emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis. Nat Rev Cancer 2005; 5 (9): 735-743
14. Skobe M, Hawighorst T, Jackson DG et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 2001; 7(2): 192-198
15. Stacker SA, Caesar C, Baldwin ME et al. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med 2001; 7 (2): 186-191 (Pubitemid 32148485)
16. Mandriota SJ, Jussila L, feilsch M et al. Vascular endothelial growth factor-C-rnediated lymphangiogenesis promotes tumour metastasis. Embo J 2001; 20 (4): 672-682
17. Hasegawa H, Mori M, Haraguchi M, Ueo H, Sugimachi K, Akiyoshi T. Expression spectrum of melanoma antigen-encoding gene family members in colorectal carcinoma. Arch Pathol Lab Med 1998; 122 (6); 551-554 (Pubitemid 28262188)
18. Weynants P, Lethe B, Brasseur F, Marchand M, Boon T. Expression of MAGE genes by non-small-cell lung carcinomas. Int J Cancer 1994; 56 (6): 826-829 (Pubitemid 24102748)
19. Frujie T, Mori M, Ueo H, Sugimachi K, Akiyoshi T. Expression of MAGE and BAGE genes in Japanese breast cancers. Ann Oncol 1997; 8 (4): 369-372
20. Rimoldi D, Salvi S, Schultz-Thater E, Spagnoli GC, Cerottini JC. AntiMAGE-3 antibody 57B and anti-MAGE-1 antibody 6C1 can be used to study different proteins of the MAGE-A family. Int J Cancer 2000; 86 (5): 749-751
21. Magrisso IJ, Richmond RE, Carter JH, Pross CB, Gilfillen RA, Carter HW. Immunohistochemical detection of RAS, JUN, FOS, and p53 oncoprotein expression in human colorectal adenomas and carcinomas. Lab Invest 1993; 69 (6): 674-681
22. Milde-Langosch K, Kappes H, Riethdorf S, Loning T, Bamberger AM. FosB is highly expressed in normal mammary epithelia, but down-regulated in poorly differentiated breast carcinomas. Breast Cancer Res Treat 2003; 77 (3): 265-275
23. Teng CS. Protooncogenes as mediators of apoptosis. Int Rev Cytol 2000; 197; 137-202
24. Milde-Langosch K. The FOS family of transcription factors and their role in tumourigenesis. Eur J Cancer 2005; 41 (16): 2449-2461 (Pubitemid 41540622)